Skip to main content
# Title Department Research Year
71 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells Department of Industrial Pharmacy 2022
72 Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis Department of Pharmaceutical Organic Chemistry 2022
73 Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1, 2, 3-triazole-4-yl derivatives as topoisomerase II inhibitors Department of Medicinal Chemistry 2022
74 Selective Cytotoxic Constituents from Gardenia latifolia and Their In Silico Topoisomerase IIα Inhibition Department of Pharmacognosy 2022
75 Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model 2022
76 Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors 2022
77 New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization Department of Pharmaceutical Organic Chemistry 2022
78 Design and optimization of metformin hydrophobic ion pairs for efcient encapsulation in polymeric drug carriers Department of Pharmaceutics 2022
79 Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors Department of Pharmaceutical Organic Chemistry 2022
80 Biomedical applications of quantum dots: overview, challenges and clinical potentials Department of Industrial Pharmacy 2022